Evidence map›Paper›PMID 26755176›Full record

ArticleEnvironmental science and pollution research international2016

Toxicity of the mixture of selected antineoplastic drugs against aquatic primary producers.

Tina Elersek, Sara Milavec, Maša Korošec, Polona Brezovsek, Noelia Negreira, Bozo Zonja, Miren López de Alda, Damià Barceló, Ester Heath, Janez Ščančar and 1 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Environmental science and pollution research international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Fate and effects of the residues of anticancer drugs in the environment.Environmental science and pollution research international · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Tina ElersekDepartment of Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna pot 111, 1000, Ljubljana, Slovenia. tina.elersek@nib.si.
Sara MilavecDepartment of Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna pot 111, 1000, Ljubljana, Slovenia.
Maša KorošecDepartment of Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna pot 111, 1000, Ljubljana, Slovenia.
Polona BrezovsekDepartment of Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna pot 111, 1000, Ljubljana, Slovenia.
Noelia NegreiraWater and Soil Quality Research Group, Department of Environmental Chemistry, Institute of Environmental Assessment and Water Research, Jordi Girona 18-26, 08034, Barcelona, Spain.
Bozo ZonjaWater and Soil Quality Research Group, Department of Environmental Chemistry, Institute of Environmental Assessment and Water Research, Jordi Girona 18-26, 08034, Barcelona, Spain.
Miren López de AldaWater and Soil Quality Research Group, Department of Environmental Chemistry, Institute of Environmental Assessment and Water Research, Jordi Girona 18-26, 08034, Barcelona, Spain.
Damià BarcelóWater and Soil Quality Research Group, Department of Environmental Chemistry, Institute of Environmental Assessment and Water Research, Jordi Girona 18-26, 08034, Barcelona, Spain.
Ester HeathJožef Stefan Institute, Jamova 39, 1000, Ljubljana, Slovenia.
Janez ŠčančarJožef Stefan Institute, Jamova 39, 1000, Ljubljana, Slovenia.
Metka FilipičDepartment of Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna pot 111, 1000, Ljubljana, Slovenia.
National Institute of Biology · SIInstitute of Environmental Assessment and Water Research · ESJožef Stefan Institute · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The residues of antineoplastic drugs are considered as new and emerging pollutants in aquatic environments. Recent experiments showed relatively high toxicity of 5-fluorouracil (5-FU), imatinib mesylate (IM), etoposide (ET) and cisplatin (CP) that are currently among most widely used antineoplastic drugs, against phytoplankton species. In this study, we investigated the toxic potential of the mixture of 5-FU + IM + ET against green alga Pseudokirchneriella subcapitata and cyanobacterium Synechococcus leopoliensis, and the stability and sorption of these drugs to algal cells. Toxic potential of the mixture was predicted by the concepts of 'concentration addition' and 'independent action' and compared to the experimentally determined toxicity. In both test species, the measured toxicity of the mixture was at effects concentrations EC10-EC50 higher than the predicted, whereas at higher effect concentration (EC90), it was lower. In general, P. subcapitata was more sensitive than S. leopoliensis. The stability studies of the tested drugs during the experiment showed that 5-FU, IM and CP are relatively stable, whereas in the cultures exposed to ET, two transformation products with the same mass as ET but different retention time were detected. The measurements of the cell-linked concentrations of the tested compounds after 72 h exposure indicated that except for CP (1.9 % of the initial concentration), these drugs are not adsorbed or absorbed by algal cells. The results of this study showed that in alga and cyanobacteria exposure to the mixture of 5-FU + ET + IM, in particular at low effect concentration range, caused additive or synergistic effect on growth inhibition, and they suggest that single compound toxicity data are not sufficient for the proper toxicity prediction for aquatic primary producers.

Indexed as

Antineoplastic AgentsChlorophytaEtoposideFluorouracilImatinib MesylatePhytoplanktonSynechococcusWater Pollutants, ChemicalAntineoplastic AgentsEtoposideFluorouracilImatinib MesylateWater Pollutants, Chemical5-fluorouracilAlgaeAntineoplasticsCisplatinCyanobacteriaEtoposideImatinib mesylateMixture toxicity

Identifiers

PMID26755176
OpenAlexW2239710164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.